510(k) Report

510(k) · Cleared

Cleared

XTRA

K112245510(k) SpecialCleared Sep 6, 201133-day reviewClass II21 CFR 868.5830

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Sorin Group Italia S.R.L. · CAC Apparatus, Autotransfusion

Cleared on Sep 6, 2011 as substantially equivalent to K101586 (Sorin Group Italia S.R.L., 2010) after a 33-day review. Its family tree reaches back 4 generations to 1989. 1 later device descends from it.

Decided
Sep 6, 2011
Review
33 days
Class
Class II
Product code
CAC
Recalls
None
Predicates
1

Its longest line of descent runs back 4 generations to K884564 (1989). 9 ancestors in all. 1 later device descends from it, 1 citing it directly.

Other ancestors, by year clearedDescendants, by year cleared 1999: 1 other ancestor1998: 2 other ancestors1995: 1 other ancestor1991: 1 other ancestor2014: 1 descendant clearedK884564 · Shiley Therapeutic Autotransfusion System-Programm · Shiley, Inc. · 1989K982650 · Autologous Blood Management System (Abms) · Dideco S.P.A. · 1998 · recalledK020647 · Dideco Electa · Dideco S.P.A. · 2002 · recalledK101586 · Xtra Autotransfusion System · Sorin Group Italia S.R.L. · 20101990200020102020
Other ancestors, by generationDescendants, by generation 3 generations back: 1 other ancestor4 generations back: 4 other ancestors 1 generation forward: 1 descendant K101586 · Xtra Autotransfusion System · Sorin Group Italia S.R.L. · 2010K020647 · Dideco Electa · Dideco S.P.A. · 2002 · recalledK982650 · Autologous Blood Management System (Abms) · Dideco S.P.A. · 1998 · recalledK884564 · Shiley Therapeutic Autotransfusion System-Programm · Shiley, Inc. · 19890
  1. Root · 4 generations backK884564 Shiley Therapeutic Autotransfusion System-ProgrammShiley, Inc. · 1989
  2. 3 generations backK982650 Autologous Blood Management System (Abms)Dideco S.P.A. · 1998 · Recalled
  3. 2 generations backK020647 Dideco ElectaDideco S.P.A. · 2002 · Recalled
  4. 1 generation backK101586 Xtra Autotransfusion SystemSorin Group Italia S.R.L. · 2010
  5. This deviceK112245 XTRASorin Group Italia S.R.L. · 2011
  6. Descendant · cites it directly · 0 of its ownK131553 XTRASorin Group Deutschland GmbH · 2014

Most influential descendants

Showing 1 of 1 · See all
  • K131553XTRASorin Group Deutschland GmbH · 2014 · cites it directly0descendants
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−4K884564Shiley Therapeutic Autotransfusion System-ProgrammShiley, Inc.1989—
−3K982650Autologous Blood Management System (Abms)Dideco S.P.A.19982
−2K020647Dideco ElectaDideco S.P.A.20022
−1K101586Xtra Autotransfusion SystemSorin Group Italia S.R.L.2010—
0 (this device)K112245XTRASorin Group Italia S.R.L.2011—
+1K131553XTRASorin Group Deutschland GmbH2014—

Other ancestors by year cleared

Year clearedDevicesWith a Class I recall
199110
199510
199820
199910

Descendants by year cleared

Year clearedDevicesWith a Class I recall
201410
FIG. 1 — Lineage of K112245, 1989–2014Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in CAC? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new CAC device

  1. #1 K240426 Aventus Clot Management Systemscore 11.2 · 4 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (1)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K101586Xtra Autotransfusion System
Summary page 1
…Autotransfusion System CLASSIFICATION NAME: Apparatus, Autotransfusion UNMODIFIED DEVICE: XTRA Autotransfusion System (#K1 01586) Classification Product Code CAC Regulation Number 868.5830 DEVICE DESCRIPTION: XTRA is an Autotransf…
Sorin Group Italia S.R.L.2010—

Also cleared against K101586: 3 other devices →

What descends from it? (1)

1 later device cites it directly; ranked here by how many devices descend from each in turn.

NumberDeviceApplicantDecidedDescendants
K131553XTRASorin Group Deutschland GmbH20140

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • The line of descent spans 22 years and passes through 3 companies; a new generation was cleared every 8.1 years on median.
  • 2 of the 9 ancestors have a recall of any class.
  • Of its descendants, K131553 (Sorin Group Deutschland GmbH, 2014) has gone furthest, with 0 descendants of its own.
  • 3 other devices also cite its predicate K101586.

How does its category compare?

All CAC devices

CAC Apparatus, Autotransfusion: FDA decisions, review times, recalls and adverse event reports over 20 years. 2011, this device’s year, is highlighted.

FDA decisions per year · CAC

3in 2024

2008: 12010: 42011: 22012: 32013: 12014: 32016: 22017: 12018: 22019: 12020: 12021: 42022: 12023: 22024: 3
2007high 4 (2010) · low 0 (2007)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · CAC

91in 2024

2010: 123 days median2012: 90 days median2014: 269 days median2021: 155 days median2024: 91 days median
2007high 269 (2014) · low 90 (2012)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · CAC

7in 2023

2007: 12008: 52009: 252010: 32011: 32013: 92017: 22018: 22019: 232023: 7, 2 Class I
2007high 25 (2009) · low 0 (2012)2026

Class I (2 since 2007) Class II/III not classified

Adverse event reports per year · CAC

128in 2025

2007: 352008: 122009: 682010: 1152011: 9392012: 2492013: 1532014: 902015: 872016: 732017: 882018: 872019: 642020: 1082021: 732022: 652023: 392024: 1292025: 128
2007high 939 (2011) · low 12 (2008)2025

MAUDE reports naming product code CAC, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20070—135
20081—512
20090—2568
201041233115
20112—3939
20123900249
20131—9153
20143269090
20150—087
20162—073
20171—288
20182—287
20191—2364
20201—0108
20214155073
20221—065
20232—7 (2)39
20243910129
20250—0128
20260—0—

What is it indicated for?

The XTRA Autotransfusion System is indicated for intraoperative recovery of blood, washing of blood collected in the postoperative period, and preoperative sequestration (with indirect patient connection). Typical clinical applications include the following surgical specialties:

*Cardiovascular

*Orthopedics

*Thoracic

*Transplant Surgery

*Emergency (Trauma)

*Neurosurgery

*Obstetrics and gynecology

*Urology

Indications for use as stated in the FDA summary.

Cite this page

510(k) Report. “K112245: XTRA.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K112245

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026